Video: Sitting Down With… John Tomtishen
October 7, 2026
Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization
1 min read
False
Advertisement
Videos
Video: From Accounting to Action on Pharma Sustainability
October 2, 2026
Ahead of CPHI Milan’s Sustainability Summit, Silvia Forroova and Rob Williams discuss how shared standards and supplier partnerships can turn commitments into measurable progress.
1 min read
Roving Reporter Asks: Is Cell and Gene Therapy Entering a More Mature Phase?
September 25, 2026
IBTV speaks with industry leaders at ASGCT 2026 about the regulatory, manufacturing, investment, and commercialization trends signaling a new phase for advanced therapies
1 min read
Roving Reporter Asks: How Is Cell and Gene Therapy Manufacturing Becoming More Scalable?
September 18, 2026
IBTV speaks with industry leaders at ASGCT 2026 about the technologies, processes, and manufacturing strategies helping advanced therapies progress toward commercial scale
1 min read
Roving Reporter Asks: How Should We Redefine Value, Access, and Affordability in Cell and Gene Therapy?
September 11, 2026
IBTV speaks with industry leaders at ASGCT 2026 about new approaches to manufacturing, reimbursement, treatment delivery, and long-term value that could bring cell and gene therapies to more patients
1 min read
Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement?
July 7, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore how cell and gene therapy companies are approaching pricing, reimbursement, and access as more potentially curative therapies reach patients
1 min read
Roving Reporter Asks: What Emerging Approaches Could Define the Next Wave of Advanced Therapies?
June 11, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy
Roving Reporter Asks: How Is Shifting Investment Reshaping Advanced Therapies?
June 4, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how a tougher funding environment is sharpening focus on scalability, cost-efficiency, partnerships, and commercialization in advanced therapies
1 min read
Roving Reporter Asks: Where Is Real Progress Being Made in Manufacturing and Supply Chain?
May 28, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery
Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs
Power List